Literature DB >> 18039082

Treatment of neurobrucellosis: what is known and what remains to be answered.

Georgios Pappas1, Nikolaos Akritidis, Leonidas Christou.   

Abstract

Neurological involvement is one of the most perplexing and diverse presentation complications of brucellosis, a worldwide prevalent zoonosis. This review presents the current knowledge available from medical literature and discusses the shortcomings of the existing data. A proposed regimen should include doxycycline and rifampicin and, with the benefit of doubt, ceftriaxone, since its high concentration in the cerebrospinal fluid may offer significant efficacy against the pathogen. Corticosteroids have been used in specialized situations. The use of streptomycin is discouraged owing to its questionable ability to penetrate into the cerebrospinal fluid and its potential neurotoxicity that may perplex the clinical presentation. Treatment duration should be individualized in the absence of an adequate cut-off index.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039082     DOI: 10.1586/14787210.5.6.983

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

1.  Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study.

Authors:  Hakan Erdem; Aysegül Ulu-Kilic; Selim Kilic; Mustafa Karahocagil; Ghaydaa Shehata; Necla Eren-Tulek; Funda Yetkin; Mustafa Kemal Celen; Nurgul Ceran; Hanefi Cem Gul; Gurkan Mert; Suda Tekin-Koruk; Murat Dizbay; Ayse Seza Inal; Saygin Nayman-Alpat; Mile Bosilkovski; Dilara Inan; Nese Saltoglu; Laila Abdel-Baky; Maria Teresa Adeva-Bartolome; Bahadir Ceylan; Suzan Sacar; Vedat Turhan; Emel Yilmaz; Nazif Elaldi; Zeliha Kocak-Tufan; Kenan Ugurlu; Basak Dokuzoguz; Hava Yilmaz; Sibel Gundes; Rahmet Guner; Nail Ozgunes; Asim Ulcay; Serhat Unal; Saim Dayan; Levent Gorenek; Ahmet Karakas; Yesim Tasova; Gaye Usluer; Yasar Bayindir; Behice Kurtaran; Oguz Resat Sipahi; Hakan Leblebicioglu
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 2.  Chronic Meningitis.

Authors:  Kiran T Thakur; Michael R Wilson
Journal:  Continuum (Minneap Minn)       Date:  2018-10

Review 3.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

Review 4.  Neurological Manifestations of Brucellosis in an Indian Population.

Authors:  Shah Faisal Ahmad Tarfarosh; Mushbiq Manzoor
Journal:  Cureus       Date:  2016-07-12

5.  Ceftriaxone use in brucellosis: A case series.

Authors:  Daniah F Fatani; Walaa A Alsanoosi; Mazen A Badawi; Abrar K Thabit
Journal:  IDCases       Date:  2019-09-05

6.  Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.

Authors:  Alina Tscherne; Enrico Mantel; Talar Boskani; Sylwia Budniak; Mandy Elschner; Antonio Fasanella; Siri L Feruglio; Domenico Galante; Christian G Giske; Roland Grunow; Judit Henczko; Christin Hinz; Wojciech Iwaniak; Daniela Jacob; Agnieszka Kedrak-Jablonska; Veronica K Jensen; Tone B Johansen; Gunnar Kahlmeter; Viviana Manzulli; Erika Matuschek; Falk Melzer; Maria S Nuncio; Joseph Papaparaskevas; Ana Pelerito; Margrete Solheim; Susanne Thomann; Athanasios Tsakris; Tara Wahab; Marcin Weiner; Lothar Zoeller; Sabine Zange
Journal:  Microorganisms       Date:  2022-07-20

7.  Subarachnoid hemorrhage secondary to Brucella-induced cerebral aneurysm: a case report.

Authors:  Yanyan Guan; Nannan Xu; Yongyuan Yao; Feng Zheng; Fengzhe Chen; Wei Wang; Xiaomeng Dong; Gang Wang
Journal:  BMC Infect Dis       Date:  2021-07-31       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.